Henry Ford Health
Dalia H. Abdullah is a seasoned member of the American Society for Clinical Pharmacology & Therapeutics and the British Pharmacological Society, actively engaged in clinical research at Henry Ford Health since April 2022, focusing on oncology drug development for Phase I and II-III studies. Dalia possesses experience in regulatory compliance, quality assurance, and patient education, working collaboratively with medical oncologists and research staff. Background includes moderating the United Conference of Pharmacovigilance and providing support to asylum seekers and refugees through the Scottish Refugee Council. Dalia's educational credentials include a BSc (Hons) in Pharmacology from Glasgow Caledonian University and a Higher qualification in Sciences from Glasgow Clyde College.
This person is not in any teams